Literature DB >> 30203027

Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease.

E Joline de Groof1,2, Jonathan H M van der Meer2,3, Pieter J Tanis1, Jessica R de Bruyn2,3, Oddeke van Ruler1, Geert R A M D'Haens2, Gijs R van den Brink2,3,4, Willem A Bemelman1, Manon E Wildenberg2,3, Christianne J Buskens1.   

Abstract

BACKGROUND AND AIMS: Rectal resection in inflammatory bowel disease [IBD] is frequently complicated by disturbed perineal wound healing. Close rectal dissection, where the mesorectum remains in situ, is hypothesized to reduce complications by minimizing dead space, compared to total mesorectal excision. The aim of this study was to analyse post-operative outcomes of both techniques. In addition, immune activity in mesorectal tissue was assessed.
METHODS: Perineal complications and healing were retrospectively assessed in a series of 74 IBD patients undergoing proctectomy using close rectal dissection or total mesorectal excision. The mesorectums of 15 patients were analysed by fluorescence-activated cell sorting, immunofluorescence and in situ hybridization. Based on the clinical and in vitro findings, a novel surgical approach for Crohn's disease patients with disturbed perineal healing after proctectomy was developed.
RESULTS: In Crohn's disease, perineal complications were more frequent after close rectal dissection than after total mesorectal excision [59.5% vs 17.6%; p = 0.007] with lower healing rates [51.4% vs 88.2%; p = 0.014]. No differences were observed in ulcerative colitis. The mesorectal tissue in Crohn's disease contained enhanced numbers of tumour necrosis factor α-producing CD14+ macrophages, with less expression of the wound-healing marker CD206. Based on these findings, mesorectal excision with omentoplasty was performed in eight patients with perineal complications after close rectal dissection, resulting in complete perineal wound closure in six. Pro-inflammatory characteristics remained present in the mesorectum after close rectal dissection in these patients.
CONCLUSIONS: In Crohn's disease, close rectal dissection resulted in more perineal complications, associated with a pro-inflammatory immune status of the mesorectal tissue. Excision of this pro-inflammatory mesenteric tissue resulted in improved perineal healing rates.
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Mesentery; macrophages; proctectomy

Mesh:

Year:  2019        PMID: 30203027     DOI: 10.1093/ecco-jcc/jjy131

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  15 in total

1.  Meta-analysis of early bowel resection versus initial medical therapy in patient's with ileocolonic Crohn's disease.

Authors:  Éanna J Ryan; Gabriel Orsi; Michael R Boland; Adeel Zafar Syed; Ben Creavin; Michael E Kelly; Kieran Sheahan; Paul C Neary; Dara O Kavanagh; Deirdre McNamara; Des C Winter; James M O'Riordan
Journal:  Int J Colorectal Dis       Date:  2020-01-09       Impact factor: 2.571

Review 2.  Intriguing Role of the Mesentery in Ileocolic Crohn's Disease.

Authors:  Giulia Turri; Michele Carvello; Nadav Ben David; Antonino Spinelli
Journal:  Clin Colon Rectal Surg       Date:  2022-04-13

Review 3.  Role of the Mesentery in Crohn's Terminal Ileitis.

Authors:  Marte A J Becker; Eline M L van der Does de Willebois; Willem A Bemelman; Manon E Wildenberg; Christianne J Buskens
Journal:  Clin Colon Rectal Surg       Date:  2022-07-04

4.  Mesenteric Excision and Exclusion for Ileocolic Crohn's Disease: Feasibility and Safety of an Innovative, Combined Surgical Approach With Extended Mesenteric Excision and Kono-S Anastomosis.

Authors:  Stefan D Holubar; Rebecca L Gunter; Benjamin H Click; Jean-Paul Achkar; Amy L Lightner; Jeremy M Lipman; Tracy L Hull; Miguel Regueiro; Florian Rieder; Scott R Steele
Journal:  Dis Colon Rectum       Date:  2022-01-01       Impact factor: 4.412

5.  Strictureplasty versus bowel resection for the surgical management of fibrostenotic Crohn's disease: a systematic review and meta-analysis.

Authors:  Waqas T Butt; Éanna J Ryan; Michael R Boland; Eilis M McCarthy; Joseph Omorogbe; Karl Hazel; Gary A Bass; Paul C Neary; Dara O Kavanagh; Deirdre McNamara; James M O'Riordan
Journal:  Int J Colorectal Dis       Date:  2020-02-11       Impact factor: 2.571

Review 6.  Surgical management of Crohn's disease: a state of the art review.

Authors:  Elise Maria Meima-van Praag; Christianne Johanna Buskens; Roel Hompes; Wilhelmus Adrianus Bemelman
Journal:  Int J Colorectal Dis       Date:  2021-02-02       Impact factor: 2.571

7.  Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn's disease.

Authors:  Francesca Aparecida Ramos da Silva; Lívia Bitencourt Pascoal; Isabella Dotti; Maria de Lourdes Setsuko Ayrizono; Daniel Aguilar; Bruno Lima Rodrigues; Montserrat Arroyes; Elena Ferrer-Picon; Marciane Milanski; Lício Augusto Velloso; João José Fagundes; Azucena Salas; Raquel Franco Leal
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

Review 8.  Pathophysiology of Crohn's disease inflammation and recurrence.

Authors:  L Petagna; A Antonelli; C Ganini; V Bellato; M Campanelli; A Divizia; C Efrati; M Franceschilli; A M Guida; S Ingallinella; F Montagnese; B Sensi; L Siragusa; G S Sica
Journal:  Biol Direct       Date:  2020-11-07       Impact factor: 4.540

Review 9.  Modern surgical strategies for perianal Crohn's disease.

Authors:  Gilmara Pandolfo Zabot; Ornella Cassol; Rogerio Saad-Hossne; Willem Bemelman
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

10.  Wound healing of metastatic perineal Crohn's disease using hyperbaric oxygen therapy: A case series.

Authors:  Corine A Lansdorp; Christianne J Buskens; Krisztina B Gecse; Geert Ram D'Haens; Rob A Van Hulst
Journal:  United European Gastroenterol J       Date:  2020-06-12       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.